SK Capital employs a sector-focused, operationally intensive investment strategy in the specialty materials, chemicals and pharmaceuticals industries.
The firm’s principals have significant industry, operating and ownership experience that enable us to identify the key value drivers of a business, price risk and reward appropriately and support management in both formulating and resourcing plans to achieve an investment’s objectives. We invest in sectors we know well, target businesses where we have a high level of conviction in our ability to generate growth and improve operations, employ capital structures that are appropriate for each investment’s specific risks and opportunities, and make investments where we believe an SK base case will generate an attractive return over the life of the investment. If our essential investment criteria are met, we are both size and geography agnostic.
SK Capital currently has $1.9 billion of assets under management, including capital from two institutional funds raised in June 2011 and November 2014.
We believe our team and strategy position us to generate consistent and attractive returns across economic cycles.
For additional information, please contact James Marden.